Cargando…
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485640/ https://www.ncbi.nlm.nih.gov/pubmed/36123015 http://dx.doi.org/10.1136/rmdopen-2022-002557 |
| _version_ | 1784792117302788096 |
|---|---|
| author | Calabrese, Cassandra Kirchner, Elizabeth Villa-Forte, Alexandra Hajj-Ali, Rula A Moss, Brandon P Fernandez, James P Calabrese, Leonard |
| author_facet | Calabrese, Cassandra Kirchner, Elizabeth Villa-Forte, Alexandra Hajj-Ali, Rula A Moss, Brandon P Fernandez, James P Calabrese, Leonard |
| author_sort | Calabrese, Cassandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9485640 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94856402022-09-20 Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity Calabrese, Cassandra Kirchner, Elizabeth Villa-Forte, Alexandra Hajj-Ali, Rula A Moss, Brandon P Fernandez, James P Calabrese, Leonard RMD Open Infections BMJ Publishing Group 2022-09-19 /pmc/articles/PMC9485640/ /pubmed/36123015 http://dx.doi.org/10.1136/rmdopen-2022-002557 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Infections Calabrese, Cassandra Kirchner, Elizabeth Villa-Forte, Alexandra Hajj-Ali, Rula A Moss, Brandon P Fernandez, James P Calabrese, Leonard Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity |
| title | Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity |
| title_full | Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity |
| title_fullStr | Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity |
| title_full_unstemmed | Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity |
| title_short | Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity |
| title_sort | early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing b cell depleting therapy and those with inborn errors of humoral immunity |
| topic | Infections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485640/ https://www.ncbi.nlm.nih.gov/pubmed/36123015 http://dx.doi.org/10.1136/rmdopen-2022-002557 |
| work_keys_str_mv | AT calabresecassandra earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity AT kirchnerelizabeth earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity AT villafortealexandra earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity AT hajjalirulaa earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity AT mossbrandonp earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity AT fernandezjamesp earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity AT calabreseleonard earlyexperiencewithtixagevimabcilgavimabpreexposureprophylaxisinpatientswithimmunemediatedinflammatorydiseaseundergoingbcelldepletingtherapyandthosewithinbornerrorsofhumoralimmunity |